Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Effect of semaglutide on weight loss and glycaemic control in patients with Prader¿Willi Syndrome and type 2 diabetes
Olga Giménez-Palop; Ana Romero; Laia Casamitjana; Rocio Pareja; Mercedes Rigla; Assumpta Caixàs;
Endocrinol Diabetes Nutr. 2024;71:83-7
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
José Antonio Gimeno Orna; Ana Belén Mañas Martínez; Luis Rodríguez Padial; Manuel Anguita Sánchez; Vivencio Barrios; Javier Muñiz García; Antonio Pérez Pérez;
Endocrinol Diabetes Nutr. 2024;71:278-89
Interpretation of clinical trials on the cardiovascular effects of hypoglycemic drugs in people with type 2 diabetes
Ana Romero; Gemma Llauradó; José-Miguel González-Clemente;
Endocrinol Diabetes Nutr. 2021;68:741-50